Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,928.64
    +479.93 (+0.93%)
     
  • CMC Crypto 200

    1,334.09
    +21.47 (+1.59%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

India's Fortis to sell Quality Healthcare to Bupa for $355 mln

MUMBAI, Oct (KOSDAQ: 039200.KQ - news) 14 (Reuters) - India's Fortis Healthcare Ltd has decided to sell its stake in Quality Healthcare Medical Services in Hong Kong to British medical services group Bupa for $355 million, as part of its efforts to reduce debt by selling some assets.

The deal is expected to be completed this month, a company statement said on Monday.

The divestment will help Fortis (Other OTC: FRTSF - news) to focus on its hospital and diagnostic business in India and further strengthen its balance sheet by improving its net debt to equity ratio and creating further room for growth, the company said.

Established in 1868, Quality Healthcare is the largest provider of healthcare services to corporations in Hong Kong, with a network of 50 medical centres, more than 500 affiliated clinics and more than 20 dental and physiotherapy centres.

ADVERTISEMENT

Quality Healthcare was bought by a vehicle owned by Fortis (KOSDAQ: 141020.KQ - news) founders Malvinder Mohan Singh and his brother Shivinder in October 2010 for about $190 million. In 2011, Fortis acquired all the international operations of the family business.

JPMorgan and Religare Capital Markets acted as advisors to Fortis on this transaction.